atural cocoa consumption in sickle cell disease
Phase 2
Not yet recruiting
- Conditions
- Genetic Diseases
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Participants who are willing to be followed for the 12-week trial period will be included in the study.
Sickle cell patients who are not on any lipid lowering drugs will be included in the RCT.
Exclusion Criteria
Participants on lipid lowering medication prior to phase II will be excluded.
Further, participants with complications (liver/renal conditions) will be excluded due to the high potassium content of cocoa
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method